STAT+: Wife of CytoDyn’s chairman sold $2.6 million in company stock ahead of Covid-19 drug study results
The wife of CytoDyn’s chairman sold $2.6 million in company stock before CytoDyn is expected to disclose results of a long-delayed clinical trial involving a treatment for patients with severe Covid-19.
Deborah Celeste Kelly, the wife of CytoDyn Chairman and Chief Medical Officer Scott Kelly, sold the company stock on Feb. 1, according to a notification of sale filed by paper to the Securities and Exchange Commission. On that same day, CytoDyn’s stock price reached its highest level in eight months.
Continue to STAT+ to read the full story…
